JB/CALL/PFIZER INC/34/0.1/20.09.24 | Market Closed - Bid/Ask 08:50:00 28/05/2024 pm IST | Pre-market 11:57:54 am | |||
| 0.03 CHF | -6.25% |
|
0.025 | -16.67% |
| Current month | +42.86% | ||
| 1 month | +42.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.03 | -6.25% |
| 22/24/22 | 0.032 | +14.29% |
Delayed Quote Swiss Exchange
Last update May 28, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| PFZXJB | |
| ISIN | CH1286513119 |
| Date issued | 12/09/2023 |
| Strike | 34 $ |
| Maturity | 20/09/2024 (115 Days) |
| Parity | 10 : 1 |
| Emission price | 0.35 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.36 CHF |
|---|---|
| Lowest since issue | 0.021 CHF |
| Spread | 0.01 CHF |
| Spread % | 33.33% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3
USD
Average target price
31.92
USD
Spread / Average Target
+12.78%
- Stock Market
- Warrants
- PFZXJB Warrant
